Sale!

Ganglioside GM1 Antibodies IgG IgM Test

Original price was: $1,126.Current price is: $800.

-29%

The Ganglioside GM1 Antibodies IgG IgM Test is a specialized diagnostic tool that detects antibodies targeting GM1 gangliosides, crucial components of nerve cell membranes. This test plays a vital role in diagnosing autoimmune neurological conditions where the immune system mistakenly attacks peripheral nerves. Measuring both IgG and IgM antibodies provides comprehensive insight into autoimmune processes affecting the nervous system. The test is particularly valuable for identifying Guillain-Barré syndrome variants, multifocal motor neuropathy, and other immune-mediated neuropathies. Patients experiencing progressive muscle weakness, numbness, or coordination difficulties benefit from this precise diagnostic approach. With results available in 2-3 weeks and a current discounted price of $800 USD, this test offers accessible neurological evaluation. Early detection through GM1 antibody testing enables timely intervention and appropriate treatment planning for autoimmune nerve disorders.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Ganglioside GM1 Antibodies IgG IgM Test

Understanding Ganglioside GM1 Antibodies Testing

The Ganglioside GM1 Antibodies IgG IgM Test represents a cutting-edge diagnostic approach in neurological medicine, specifically designed to detect autoimmune responses against ganglioside GM1 – a crucial glycolipid component of nerve cell membranes. This sophisticated immunoassay provides essential insights into immune-mediated neurological disorders where the body’s defense system mistakenly targets peripheral nerves.

What Are Ganglioside GM1 Antibodies?

Ganglioside GM1 antibodies are autoantibodies produced by the immune system that specifically target GM1 gangliosides, which are abundant in the myelin sheath and axonal membranes of peripheral nerves. When these antibodies develop, they can disrupt normal nerve function by interfering with signal transmission and causing inflammatory damage to nerve structures.

What This Test Measures and Detects

The Ganglioside GM1 Antibodies IgG IgM Test precisely measures:

  • IgG Antibodies: Immunoglobulin G antibodies against GM1 gangliosides, typically associated with chronic autoimmune conditions
  • IgM Antibodies: Immunoglobulin M antibodies targeting GM1, often linked to acute or subacute neurological presentations
  • Antibody Titers: Quantitative levels of both antibody classes to assess disease activity and monitor treatment response

Clinical Significance of GM1 Antibody Detection

Detection of GM1 antibodies provides critical diagnostic information for several neurological conditions:

  • Multifocal Motor Neuropathy (MMN): High association with anti-GM1 IgM antibodies
  • Guillain-Barré Syndrome (GBS): Particularly the acute motor axonal neuropathy (AMAN) variant
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Specific antibody patterns aid in subtype classification
  • Motor Neuron Disease: Helps differentiate from autoimmune neuropathies with similar presentations

Who Should Consider Ganglioside GM1 Antibodies Testing?

This test is recommended for individuals experiencing symptoms suggestive of autoimmune neurological disorders:

Symptoms Indicating Need for Testing

  • Progressive Muscle Weakness: Particularly affecting limbs asymmetrically
  • Sensory Disturbances: Numbness, tingling, or burning sensations in extremities
  • Motor Function Impairment: Difficulty with fine motor tasks, grip strength reduction
  • Coordination Problems: Unsteady gait, balance issues, or frequent stumbling
  • Muscle Cramping and Fasciculations: Involuntary muscle twitching or cramping
  • Rapid Onset Weakness: Sudden development of motor symptoms over days to weeks

Patient Populations at Higher Risk

  • Patients with suspected immune-mediated neuropathies
  • Individuals with progressive neurological symptoms of unknown origin
  • Patients not responding to conventional neurological treatments
  • Those with family history of autoimmune disorders
  • Individuals following viral infections or vaccinations with neurological complications

Benefits of Ganglioside GM1 Antibodies Testing

Diagnostic Precision and Treatment Guidance

This test offers multiple clinical advantages:

  • Accurate Diagnosis: Provides definitive evidence of autoimmune nerve involvement
  • Treatment Selection: Guides appropriate immunotherapy choices based on antibody profile
  • Disease Monitoring: Enables tracking of treatment response through antibody level changes
  • Prognostic Information: Helps predict disease course and potential complications
  • Differential Diagnosis: Distinguishes autoimmune neuropathies from other neurological conditions

Early Intervention Opportunities

Early detection of GM1 antibodies allows for:

  • Prompt initiation of immunomodulatory therapies
  • Prevention of progressive nerve damage
  • Improved long-term neurological outcomes
  • Reduced disability and improved quality of life

Understanding Your Test Results

Interpretation Guidelines

Your Ganglioside GM1 Antibodies results will be interpreted by our expert neurologists:

Positive Results May Indicate:

  • High IgM Titers: Often associated with multifocal motor neuropathy
  • Elevated IgG Levels: May suggest Guillain-Barré syndrome or chronic inflammatory neuropathies
  • Combined Elevations: Could indicate complex autoimmune neurological conditions

Negative Results Typically Mean:

  • Low probability of GM1 antibody-mediated neuropathy
  • Alternative diagnoses should be considered
  • May require additional autoimmune neurological testing

Clinical Correlation Importance

Results are always interpreted in the context of:

  • Clinical symptoms and neurological examination findings
  • Electrodiagnostic studies (EMG/NCS)
  • Other laboratory parameters
  • Response to previous treatments

Test Information and Pricing

Test Parameter Details
Test Name Ganglioside GM1 Antibodies IgG IgM Test
Discount Price $800 USD
Regular Price $1126 USD
Turnaround Time Sample by 7th of the month; Report after 2-3 weeks
Sample Type 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Specialty Neurology
Method Immunoassay

Pre-Test Instructions

  • Overnight fasting is preferred for optimal results
  • Complete Test Send Out Consent Form (Form 35) is mandatory
  • Inform your physician about current medications
  • Schedule sample collection appropriately

Nationwide Testing Availability

GGC DNA provides comprehensive Ganglioside GM1 Antibodies testing across the United States with convenient locations in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas facilities
  • Miami, Orlando, and Florida centers
  • Seattle, Portland, and Pacific Northwest sites
  • Boston, Philadelphia, and Northeast locations

Take Control of Your Neurological Health Today

Don’t let unexplained neurological symptoms compromise your quality of life. The Ganglioside GM1 Antibodies IgG IgM Test provides the clarity needed for accurate diagnosis and effective treatment planning. Our specialized neurological testing services combine cutting-edge technology with expert interpretation to deliver reliable results you can trust.

Ready to Schedule Your Test?

Call or WhatsApp us today at +1(267) 388-9828 to book your Ganglioside GM1 Antibodies IgG IgM Test. Our knowledgeable staff will guide you through the process, answer your questions, and help you schedule at a location convenient for you. Take the first step toward understanding your neurological health with confidence and precision.

Early detection through specialized autoimmune neurological testing can make a significant difference in treatment outcomes and long-term neurological function. Trust GGC DNA for comprehensive, accurate neurological diagnostics.